Oncology Genetics – Genetic Testing Company | The DNA …
richards | April 14, 2016
Test Gene(s) Further Information BRCA1 and BRCA2 Sequencing and Del/DupAnalysis BRCA1, BRCA2 BRCA1 and BRCA2 Ashkenazi Founder Panel BRCA1/ BRCA2 Targeted Pathogenic Variant Analysis (BRCA1 c.68_69delAG [also known as 185delAGor 187delAG], c.5266dupC [also known as 5382insC or 5385insC] and BRCA2c.5946delT [also knownas 6174delT]) Comprehensive Cancer Panel (32 Genes) APC, ATM, AXIN2, BARD1, BMPR1A, BRCA1, BRCA2, BRIP1, CDH1, CDK4, CDKN2A, CHEK2, EPCAM,FANCC, MLH1, MSH2, MSH6, MUTYH, NBN, PALB2, PMS2, POLD1, POLE, PTEN, RAD51C, RAD51D, SCG5/GREM1, SMAD4, STK11, TP53, VHL, XRCC2 Breast Cancer High Risk Panel (6 Genes) Breast Cancer High Risk Panel and PALB2 (7 Genes) Breast Cancer High/Moderate Risk Panel (9 Genes) ATM, BRCA1, BRCA2, CDH1, CHEK2, PALB2, PTEN, STK11, TP53 Lynch/Colorectal High Risk Panel (7 Genes) APC, EPCAM, MLH1, MSH2, MSH6, MUTYH, PMS2 MSH2 Exon 1-7 Inversion Analysis MSH2 Familial Cutaneous Malignant Melanoma (2 Genes) CDKN2A, CDK4 Pancreatic Cancer Panel (16Genes) APC, ATM, BRCA1, BRCA2, CDK4, CDKN2A, EPCAM, MLH1, MSH2, MSH6, PALB2,PMS2, STK11, TP53, VHL, XRCC2 Pediatric Tumor Panel (27 genes) ALK, APC, CDC73, DICER1, EPCAM, MEN1, MLH1, MSH2, MSH6, NF1, NF2, PHOX2B, PMS2, PRKAR1A, PTCH1, PTEN, RB1, RET, SMARCA4, SMARCB1, STK11, SUFU, TP53, TSC1, TSC2, VHL, WT1 PGL/PCC (Paraganglioma/Pheochromocytoma) Panel (12 Genes) FH, MAX, MEN1, NF1, RET, SDHA, SDHAF2, SDHB, SDHC, SDHD, TMEM127, VHL Renal Cancer Panel(18 Genes) Rest of Comprehensive Cancer Panel (if subpanel negative)
